Benitec Biopharma (BNTC)
Benitec Biopharma on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as pharmaceutical preparations.
2.0M
Short interest
settlement 2026-10-15
10.1
Days to cover
-0.1 days vs prior
76.1%
Short share of volume
2026-11-03
49,715
Fails to deliver
settlement 2026-10-08
Fri 13 Nov
Next earnings
estimated date
$0
Insider flow, 90 days
0 buys, 0 sells
As of 2026-11-03.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in BNTC is 1,992,032 shares, down 194,110 shares over the last month. Over the last 48 readings it ranged from 33,107 shares (15 November 2024) to 2,405,071 shares (15 June 2026). At the reported average volume of 198K shares a day that is 10.1 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/bntc" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 1,992,032 | -2.3% | 197,761 | 10.07 |
| 2026-09-30 | 2,039,457 | -6.7% | 200,147 | 10.19 |
| 2026-09-15 | 2,186,142 | -1.3% | 109,463 | 19.97 |
| 2026-08-31 | 2,214,538 | +5.1% | 154,962 | 14.29 |
| 2026-08-14 | 2,107,348 | -1.8% | 211,986 | 9.94 |
| 2026-07-31 | 2,146,708 | -5.4% | 80,283 | 26.74 |
| 2026-07-15 | 2,269,662 | +1.8% | 96,657 | 23.48 |
| 2026-06-30 | 2,228,682 | -7.3% | 214,322 | 10.40 |
| 2026-06-15 | 2,405,071 | +3.1% | 83,370 | 28.85 |
| 2026-05-29 | 2,332,180 | +3.6% | 75,779 | 30.78 |
| 2026-05-15 | 2,251,632 | -2.9% | 97,935 | 22.99 |
| 2026-04-30 | 2,318,612 | +2.3% | 107,717 | 21.53 |
| 2026-04-15 | 2,266,291 | -1.7% | 104,876 | 21.61 |
| 2026-03-31 | 2,305,987 | +7.1% | 168,952 | 13.65 |
| 2026-03-13 | 2,152,891 | +6.7% | 257,774 | 8.35 |
| 2026-02-27 | 2,018,595 | -4.9% | 150,976 | 13.37 |
| 2026-02-13 | 2,123,180 | +1.5% | 129,727 | 16.37 |
| 2026-01-30 | 2,091,235 | +7.9% | 107,598 | 19.44 |
| 2026-01-15 | 1,938,297 | -1.3% | 145,771 | 13.30 |
| 2025-12-31 | 1,963,460 | +23.8% | 236,157 | 8.31 |
| 2025-12-15 | 1,585,527 | -4.5% | 279,753 | 5.67 |
| 2025-11-28 | 1,660,549 | +17.6% | 171,885 | 9.66 |
| 2025-11-14 | 1,412,511 | +22.4% | 499,479 | 2.83 |
| 2025-10-31 | 1,153,794 | +2.4% | 46,038 | 25.06 |
| 2025-10-15 | 1,127,047 | -14.3% | 81,132 | 13.89 |
| 2025-09-30 | 1,315,910 | +0.6% | 49,002 | 26.85 |
| 2025-09-15 | 1,308,292 | -1.4% | 33,690 | 38.83 |
| 2025-08-29 | 1,326,689 | -4.8% | 39,361 | 33.71 |
| 2025-08-15 | 1,393,677 | -2.9% | 43,640 | 31.94 |
| 2025-07-31 | 1,434,551 | -0.5% | 77,401 | 18.53 |
| 2025-07-15 | 1,441,240 | +25.4% | 100,919 | 14.28 |
| 2025-06-30 | 1,149,592 | +117.9% | 371,226 | 3.10 |
| 2025-06-13 | 527,600 | +18.4% | 49,585 | 10.64 |
| 2025-05-30 | 445,550 | +1.4% | 43,153 | 10.32 |
| 2025-05-15 | 439,202 | +24.1% | 37,065 | 11.85 |
| 2025-04-30 | 354,058 | +23.0% | 33,092 | 10.70 |
| 2025-04-15 | 287,817 | -2.2% | 53,743 | 5.36 |
| 2025-03-31 | 294,203 | +36.1% | 74,034 | 3.97 |
| 2025-03-14 | 216,131 | +23.6% | 37,050 | 5.83 |
| 2025-02-28 | 174,803 | +17.6% | 27,221 | 6.42 |
| 2025-02-14 | 148,669 | +16.1% | 29,803 | 4.99 |
| 2025-01-31 | 127,995 | +3.1% | 19,828 | 6.46 |
| 2025-01-15 | 124,104 | +99.3% | 47,229 | 2.63 |
| 2024-12-31 | 62,271 | +65.5% | 114,275 | 1.00 |
| 2024-12-13 | 37,636 | +6.3% | 60,760 | 1.00 |
| 2024-11-29 | 35,423 | +7.0% | 34,887 | 1.02 |
| 2024-11-15 | 33,107 | -41.8% | 35,740 | 1.00 |
| 2024-10-31 | 56,887 | +49.0% | 34,166 | 1.67 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 3 November 2026, the short share of BNTC volume is 76.1%, up 38.6 points over the last five sessions. Over the last 30 readings it ranged from 27.1% (28 October 2026) to 87.0% (30 September 2026). The latest reading is 19.9 points above the 30-session average of 56.3%, on 35K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-03 | 27K | 35K | 76.1% | 6,066 |
| 2026-11-02 | 52K | 74K | 69.9% | 0 |
| 2026-10-30 | 35K | 52K | 66.7% | 0 |
| 2026-10-29 | 26K | 56K | 46.1% | 0 |
| 2026-10-28 | 25K | 91K | 27.1% | 9,900 |
| 2026-10-27 | 15K | 39K | 37.5% | 0 |
| 2026-10-26 | 21K | 33K | 65.1% | 0 |
| 2026-10-23 | 25K | 43K | 56.5% | 0 |
| 2026-10-22 | 22K | 60K | 37.3% | 0 |
| 2026-10-21 | 36K | 62K | 57.5% | 0 |
| 2026-10-20 | 48K | 173K | 27.8% | 15,000 |
| 2026-10-19 | 42K | 69K | 60.1% | 0 |
| 2026-10-16 | 24K | 47K | 51.1% | 0 |
| 2026-10-15 | 27K | 35K | 77.6% | 0 |
| 2026-10-14 | 31K | 66K | 47.1% | 0 |
| 2026-10-13 | 28K | 47K | 59.9% | 0 |
| 2026-10-12 | 50K | 70K | 71.4% | 0 |
| 2026-10-09 | 15K | 22K | 65.5% | 0 |
| 2026-10-08 | 36K | 59K | 60.3% | 0 |
| 2026-10-07 | 26K | 48K | 53.3% | 0 |
| 2026-10-06 | 29K | 55K | 53.4% | 0 |
| 2026-10-05 | 87K | 248K | 34.9% | 0 |
| 2026-10-02 | 27K | 44K | 61.8% | 327 |
| 2026-10-01 | 15K | 29K | 51.0% | 0 |
| 2026-09-30 | 38K | 43K | 87.0% | 0 |
| 2026-09-29 | 32K | 52K | 61.6% | 100 |
| 2026-09-28 | 38K | 59K | 65.2% | 0 |
| 2026-09-25 | 17K | 33K | 50.1% | 0 |
| 2026-09-24 | 58K | 88K | 65.8% | 2,814 |
| 2026-09-23 | 98K | 229K | 42.6% | 324 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 8 October 2026, the fails-to-deliver balance in BNTC is 49,715 shares, up 49,477 shares over the last settlement date. Over the last 30 readings it ranged from 7 shares (16 June 2026) to 49,715 shares (8 October 2026). The latest reading sits at the top of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-08 | 49,715 | $8.99 | $447K |
| 2026-09-28 | 238 | $9.59 | $2K |
| 2026-09-24 | 278 | $9.83 | $3K |
| 2026-09-16 | 36,350 | $11.05 | $402K |
| 2026-09-02 | 19 | $12.31 | $234 |
| 2026-08-31 | 1,942 | $12.47 | $24K |
| 2026-08-27 | 10 | $12.88 | $129 |
| 2026-08-25 | 63 | $12.71 | $801 |
| 2026-08-14 | 4,910 | $12.56 | $62K |
| 2026-08-12 | 15 | $13.48 | $202 |
| 2026-08-07 | 17 | $13.13 | $223 |
| 2026-08-06 | 2,127 | $12.69 | $27K |
| 2026-08-05 | 285 | $12.52 | $4K |
| 2026-07-29 | 233 | $11.89 | $3K |
| 2026-07-14 | 220 | $12.99 | $3K |
| 2026-07-07 | 8,389 | $13.20 | $111K |
| 2026-06-30 | 38,525 | $12.70 | $489K |
| 2026-06-29 | 26,378 | $12.37 | $326K |
| 2026-06-25 | 2,876 | $13.63 | $39K |
| 2026-06-16 | 7 | $11.33 | $79 |
| 2026-06-15 | 1,735 | $11.18 | $19K |
| 2026-06-12 | 7,740 | $11.05 | $86K |
| 2026-06-03 | 630 | $10.58 | $7K |
| 2026-05-18 | 373 | $11.49 | $4K |
| 2026-04-21 | 30 | $13.99 | $420 |
| 2026-04-20 | 108 | $14.08 | $2K |
| 2026-04-02 | 207 | $10.97 | $2K |
| 2026-04-01 | 1,427 | $10.65 | $15K |
| 2026-03-26 | 195 | $10.84 | $2K |
| 2026-03-23 | 5,959 | $10.98 | $65K |
Insider trades
SEC Form 4, newest first. JSONNo open-market insider trades were reported for BNTC in the last 90 days. The most recent filings are listed below. Latest filing: BUCHI J KEVIN (Director) on 2026-06-29.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-06-29 | BUCHI J KEVIN | Director | Gift | 52K | $0.00 | $0 | 52K |
| 2025-12-29 | Cowen Aaron | Director,TenPercentOwner | Buy | 12K | $13.44 | $156K | 1.8M |
| 2025-12-29 | Cowen Aaron | Director,TenPercentOwner | Buy | 66K | $13.44 | $884K | 9.7M |
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 12K | $13.44 | $156K | 1.8M |
| 2025-12-29 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 66K | $13.44 | $884K | 9.7M |
| 2025-12-26 | Cowen Aaron | Director,TenPercentOwner | Buy | 3K | $13.10 | $33K | 1.8M |
| 2025-12-26 | Cowen Aaron | Director,TenPercentOwner | Buy | 14K | $13.10 | $188K | 9.6M |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 3K | $13.10 | $33K | 1.8M |
| 2025-12-26 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 14K | $13.10 | $188K | 9.6M |
| 2025-12-23 | Cowen Aaron | Director,TenPercentOwner | Buy | 43K | $12.85 | $547K | 9.6M |
| 2025-12-23 | Cowen Aaron | Director,TenPercentOwner | Buy | 7K | $12.85 | $95K | 1.8M |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 7K | $12.85 | $95K | 1.8M |
| 2025-12-23 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 43K | $12.85 | $547K | 9.6M |
| 2025-12-22 | Averill Madison Master Fund, Ltd. | TenPercentOwner | Buy | 3K | $12.08 | $35K | 1.8M |
| 2025-12-22 | Averill Madison Master Fund, Ltd. | TenPercentOwner | Buy | 17K | $12.08 | $201K | 9.6M |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 3K | $12.08 | $35K | 1.8M |
| 2025-12-22 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 17K | $12.08 | $201K | 9.6M |
| 2025-12-19 | Averill Madison Master Fund, Ltd. | TenPercentOwner | Buy | 14K | $11.48 | $160K | 9.6M |
| 2025-12-19 | Averill Madison Master Fund, Ltd. | TenPercentOwner | Buy | 2K | $11.48 | $28K | 1.8M |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 2K | $11.48 | $28K | 1.8M |
| 2025-12-19 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 14K | $11.48 | $160K | 9.6M |
| 2025-12-18 | Averill Madison Master Fund, Ltd. | TenPercentOwner | Buy | 2K | $11.24 | $17K | 1.8M |
| 2025-12-18 | Averill Madison Master Fund, Ltd. | TenPercentOwner | Buy | 9K | $11.24 | $98K | 9.5M |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 2K | $11.24 | $17K | 1.8M |
| 2025-12-18 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 9K | $11.24 | $98K | 9.5M |
| 2025-11-07 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 751K | $13.50 | $10.1M | 1.8M |
| 2025-11-07 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director, 10% owner | Buy | 730K | $13.50 | $9.9M | 9.5M |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | Buy | 1K | $12.63 | $16K | 1.1M |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | Buy | 10K | $12.63 | $120K | 8.8M |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | Buy | 670 | $13.22 | $9K | 1.1M |
| 2025-03-31 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | Buy | 5K | $13.22 | $67K | 8.8M |
| 2025-03-26 | Cowen Aaron | TenPercentOwner | Buy | 106K | $13.00 | $1.4M | 1.1M |
| 2025-03-26 | Cowen Aaron | TenPercentOwner | Buy | 794K | $13.00 | $10.3M | 8.8M |
| 2025-03-12 | BUCHI J KEVIN | Director | Gift | 104K | $0.00 | $0 | 104K |
| 2025-03-12 | BUCHI J KEVIN | Director | Gift | 104K | $0.00 | $0 | 284 |
| 2025-02-27 | BUCHI J KEVIN | Director | Exercise or conversion | 52K | $3.86 | $200K | 104K |
| 2024-12-24 | Cowen Aaron | TenPercentOwner | Buy | 18K | $11.25 | $199K | 8.0M |
| 2024-12-24 | Cowen Aaron | TenPercentOwner | Buy | 2K | $11.25 | $26K | 961K |
| 2024-12-23 | Cowen Aaron | TenPercentOwner | Buy | 3K | $10.98 | $34K | 958K |
| 2024-12-23 | Cowen Aaron | TenPercentOwner | Buy | 24K | $10.98 | $267K | 8.0M |
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | Buy | 37K | $9.60 | $357K | 8.0M |
| 2024-12-03 | SUVRETTA CAPITAL MANAGEMENT, LLC | Director,TenPercentOwner | Buy | 5K | $9.60 | $46K | 955K |
| 2024-11-20 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Buy | 24K | $10.22 | $249K | 7.9M |
| 2024-11-20 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Buy | 3K | $10.22 | $31K | 950K |
| 2024-11-19 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Buy | 12K | $9.73 | $121K | 7.9M |
| 2024-11-19 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Buy | 2K | $9.73 | $15K | 947K |
| 2024-09-26 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Exercise (in or at the money) | 4.6M | $3.86 | $17.8M | 6.7M |
| 2024-09-26 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Exercise (in or at the money) | 588K | $1.93 | $1.1M | 2.1M |
| 2024-09-26 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Exercise (in or at the money) | 148K | $0.00 | $0 | 946K |
| 2024-09-26 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Exercise (in or at the money) | 576K | $3.86 | $2.2M | 797K |
| 2024-09-26 | Averill Master Fund, Ltd. | Director,TenPercentOwner | Exercise (in or at the money) | 1.2M | $0.00 | $0 | 7.9M |
| 2023-08-11 | BUCHI J KEVIN | Director | Buy | 52K | price not stated in the filing | not stated | 52K |
| 2023-08-11 | Boston Megan | Executive Director | Buy | 26K | price not stated in the filing | not stated | 26K |
| 2021-12-09 | Oliveira Steven Michael | TenPercentOwner | Buy | 11K | $3.04 | $32K | 1.0M |
| 2021-11-29 | Oliveira Steven Michael | TenPercentOwner | Buy | 38K | $3.18 | $121K | 989K |
| 2021-05-03 | Oliveira Steven Michael | TenPercentOwner | Buy | 41K | $4.25 | $172K | 952K |
| 2021-04-30 | Oliveira Steven Michael | TenPercentOwner | Buy | 120K | $4.18 | $502K | 911K |
| 2021-04-29 | Oliveira Steven Michael | TenPercentOwner | Buy | 23K | $5.49 | $126K | 791K |
| 2021-04-28 | Oliveira Steven Michael | TenPercentOwner | Buy | 100K | $5.45 | $545K | 768K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON12 holders report 5% or more of BNTC in their latest filing, 4 on Schedule 13D (active intent). The largest reported stake is SUVRETTA CAPITAL MANAGEMENT, LLC at 44.1% of the class (17,761,945 shares), filed 2025-11-10 for an event on 2025-11-07.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-01-29 | 13G/Ano. 7 | Franklin Advisers, Inc.investment adviser, corporation | 3.8M | 10.6% | 2025-12-31 |
| 2026-01-29 | 13G/Ano. 7 | Franklin Resources, Inc.parent holding company, corporation | 3.8M | 10.6% | 2025-12-31 |
| 2026-01-29 | 13G/Ano. 7 | Charles B. Johnsonparent holding company, individual | 0 | 0.0% | 2025-12-31 |
| 2026-01-29 | 13G/Ano. 7 | Rupert H. Johnson, Jr.parent holding company, individual | 0 | 0.0% | 2025-12-31 |
| 2025-12-08 | 13G/Ano. 10 | JANUS HENDERSON GROUP PLCinvestment adviser, parent holding company | 3.4M | 10.0% | 2025-11-28 |
| 2025-12-08 | 13G/Ano. 10 | Janus Henderson Biotech Innovation Master Fund Ltdinvestment company | 2.1M | 6.1% | 2025-11-28 |
| 2025-12-03 | 13G | RA Capital Healthcare Fund, L.P.partnership | 1.9M | 5.5% | 2025-11-07 |
| 2025-12-03 | 13G | RA Capital Management, L.P.investment adviser, partnership | 1.9M | 5.5% | 2025-11-07 |
| 2025-12-03 | 13G | Peter Kolchinskyparent holding company, individual | 1.9M | 5.5% | 2025-11-07 |
| 2025-12-03 | 13G | Rajeev Shahparent holding company, individual | 1.9M | 5.5% | 2025-11-07 |
| 2025-11-10 | 13D/Ano. 4 | SUVRETTA CAPITAL MANAGEMENT, LLCinvestment adviser, other entity | 17.8M | 44.1% | 2025-11-07 |
| 2025-11-10 | 13D/Ano. 4 | Aaron Cowenindividual, parent holding company | 17.8M | 44.1% | 2025-11-07 |
| 2025-11-10 | 13D/Ano. 4 | Averill Master Fund, Ltd.corporation | 15.2M | 37.8% | 2025-11-07 |
| 2025-11-10 | 13D/Ano. 4 | Averill Madison Master Fund, Ltd.corporation | 2.5M | 6.3% | 2025-11-07 |
13F holders
Tracked managers holding BNTC at their latest 13F. JSON3 of the 30 tracked managers held BNTC at their latest 13F, $13.7M in total at quarter-end prices. Millennium Management is the largest at $12.3M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Millennium Management | 2026-06-30 | 921K | $12.3M | 0.00% | +269K |
| Citadel Advisors | 2026-06-30 | 81K | $1.1M | 0.00% | -90K |
| AQR Capital Management | 2026-06-30 | 22K | $301K | 0.00% | new |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
Benitec Biopharma in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows Benitec Biopharma (BNTC), SEC CIK 1808898, listed on Nasdaq, classified by the SEC as pharmaceutical preparations. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-03.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-08.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-01-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-09-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-29.JSON and CSV
- Company record
- EDGAR filing index for CIK 1808898Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as pharmaceutical preparations
Other company pages
Datasets
Frequently Asked Questions
How much of BNTC is sold short?
What is BNTC's daily short volume?
Does BNTC have fails to deliver?
Are BNTC insiders buying or selling?
Who owns 5% or more of BNTC?
Which tracked 13F managers own BNTC?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.